Successful treatment of prolonged COVID-19 with remdesivir and nirmatrelvir/ritonavir in a patient with a history of diffuse large B-cell lymphoma: a case report

Abstract Background Immunocompromised individuals, such as those affected by and treated for hematological malignancies, face a higher risk of prolonged SARS-CoV-2 infection. Increased disease risk is further compounded by limited treatment options. Currently, approved antiviral monotherapies agains...

Full description

Bibliographic Details

Published in:	Journal of the Egyptian National Cancer Institute
Main Authors:	Nadia Bouhamdani, Dominique Bouhamdani, Cynthia Léger, Josiane Stadler, Nancy Saulnier
Format:	Article
Language:	English
Published:	SpringerOpen 2025-06-01
Subjects:	COVID- 19 SARS-CoV- 2 Hematological malignancies Diffuse large B-cell lymphoma Remdesivir Veklury
Online Access:	https://doi.org/10.1186/s43046-025-00291-1